EDGAR Filing Documents for 0001558370-16-009365

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001558370-16-009365

Filing Date

2016-11-04

Accepted

2016-11-04 16:07:46

Documents

Period of Report

2016-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	nviv-20160930x10q.htm	10-Q	764590
2	EX-10.1	nviv-20160930ex10117ec2f.htm	EX-10.1	134051
3	EX-31.1	nviv-20160930ex311e151fb.htm	EX-31.1	15236
4	EX-31.2	nviv-20160930ex312b75b7e.htm	EX-31.2	15236
5	EX-32.1	nviv-20160930ex321bb1860.htm	EX-32.1	8037
6	EX-32.2	nviv-20160930ex32279c9ae.htm	EX-32.2	8046
	Complete submission text file	0001558370-16-009365.txt		4089905

Data Files

Seq	Description	Document	Type	Size
7	EX-101.INS	nviv-20160930.xml	EX-101.INS	750218
8	EX-101.SCH	nviv-20160930.xsd	EX-101.SCH	35490
9	EX-101.CAL	nviv-20160930_cal.xml	EX-101.CAL	31785
10	EX-101.DEF	nviv-20160930_def.xml	EX-101.DEF	126752
11	EX-101.LAB	nviv-20160930_lab.xml	EX-101.LAB	360221
12	EX-101.PRE	nviv-20160930_pre.xml	EX-101.PRE	258272

Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524

INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)